PDCD1 and neoplasm: Miltefosine-treated mice almost completely cleared tumor and had higher CAR-T cell percentage in peripheral blood at the last time point, while anti-PD-1 therapy did not show any benefit compared with M28Z CAR-T cell (Figures 7F and 7G).